Ginsenoside Rg5 Alleviates 1-Methyl-4-Phenylpyridinium Ion Induced Parkinson's Disease Cell Model Damage by Regulating MicroRNA-874-3p/Thioredoxin Interacting Proteins Molecular Axis

被引:0
|
作者
Zhang, Jidong [1 ]
Rong, Zhao [1 ]
Hu, Juan [2 ]
Sun, Xuju [3 ]
机构
[1] Huazhong Univ Sci & Technol, Dept Pharm, Wuhan 430074, Peoples R China
[2] Huazhong Univ Sci & Technol, Surg Dept, Wuhan 430074, Peoples R China
[3] Huazhong Univ Sci & Technol, Liyuan Hosp, Dept Pharm, Tongji Med Coll, Wuhan 430077, Peoples R China
关键词
Ginsenoside Rg5; Parkinson's disease; microRNA-874-3p; thioredoxin interacting proteins; 1-methyl-4-phenylpyridine ion; DOWN-REGULATION; MIR-874-3P;
D O I
10.36468/pharmaceutical-sciences.885
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This research attempts to probe into the influence mechanism of ginsenoside Rg5 on 1-methyl-4-phenylpyridine ion induced Parkinson's disease cell model damage. Different concentrations (25, 50, 100 mu mol/l) of ginsenoside Rg5 acted on human neuroblastoma SK-N-SH cells induced by 1-methyl-4-phenylpyridine ion. Adopt cell counting kit-8, flow cytometry, quantitative reverse transcription polymerase chain reaction and western blot to exam cell viability, apoptosis rate, microRNA-874-3p and thioredoxin interacting proteins expressions. Transfected microRNA-874-3p mimics and thioredoxin interacting proteins small interfering RNA to SK-N-SH cells, respectively. Then adopt the above mentioned methods to exam microRNA-874-3p overexpression or thioredoxin interacting proteins inhibition influence on SK-N-SH cells viability and apoptosis which is induced by 1-methyl-4-phenylpyridine ion. Adopt dual luciferase report experiment and western blot methods to test the regulatory function of microRNA-874-3p on thioredoxin interacting proteins. After ginsenoside Rg5 acted on 1-methyl-4-phenylpyridine ion induced SK-N-SH cells, the cell viability and microRNA-874-3p expression increased significantly, but thioredoxin interacting proteins expression and apoptosis rate decreased significantly (p<0.05). After microRNA-874-3p over-expressing, 1-methyl-4-phenylpyridine ion induced SK-N-SH cells viability were significantly increased and apoptosis rate was remarkably reduced (p<0.05). After inhibiting thioredoxin interacting proteins expression, 1-methyl-4-phenylpyridine ion induced SK-N-SH cells viability was significantly increased, but apoptosis rate was remarkably lowered (p<0.05). MicroRNA-874-3p regulates thioredoxin interacting proteins expression negatively. MicroRNA-874-3p inhibition could attenuate the effect of ginsenoside Rg5 on the viability and apoptosis of 1-methyl-4-phenylpyridine ion induced SK-N-SH (p<0.05). Thioredoxin interacting proteins inhibition went into reverse microRNA-874-3p inhibition combined with ginsenoside Rg5 treatment on 1-methyl-4-phenylpyridine ion induced SK-N-SH activity and apoptosis (p<0.05). Ginsenoside Rg5 could alleviate 1-methyl-4-phenylpyridine ion induced Parkinson's disease cell model damage and its mechanism possibly has relationship with the up-regulation of microRNA-874-3p/thioredoxin interacting proteins molecular axis.
引用
收藏
页码:1295 / 1303
页数:9
相关论文
共 15 条
  • [1] Regulatory Role and Molecular Mechanism of Mammalian Sterile 20-Like Kinase 1 in 1-Methyl-4-Phenylpyridinium Ion-Induced Parkinson's Disease Cell Model
    Zhang, Jun
    Liu, Jie
    Li, Yongle
    Zhang, Xuexian
    Yang, Chunxiang
    REJUVENATION RESEARCH, 2024, 27 (05) : 154 - 162
  • [2] Myeloid cell leukemia 1 (Mcl−1) protects against 1-methyl-4-phenylpyridinium ion (MPP+) induced apoptosis in Parkinson’s disease
    Lijing Fan
    Li Jiang
    Zhongde Du
    Metabolic Brain Disease, 2015, 30 : 1269 - 1274
  • [3] Myeloid cell leukemia 1 (Mcl-1) protects against 1-methyl-4-phenylpyridinium ion (MPP plus ) induced apoptosis in Parkinson's disease
    Fan, Lijing
    Jiang, Li
    Du, Zhongde
    METABOLIC BRAIN DISEASE, 2015, 30 (05) : 1269 - 1274
  • [4] The Neuroprotective Effect of Steroid Receptor Coactivator-Interacting Protein (SIP) in Astrocyte Model of 1-Methyl-4-Phenylpyridinium (MPP+)- Induced Parkinson's Disease
    Qu, Mingwei
    MEDICAL SCIENCE MONITOR, 2019, 25 : 5776 - 5784
  • [5] Mir-141-3p Regulates Apoptosis and Mitochondrial Membrane Potential via Targeting Sirtuin1 in a 1-Methyl-4-Phenylpyridinium in vitro Model of Parkinson's Disease
    Zheng, Yumin
    Dong, Li
    Liu, Na
    Luo, Xiaoguang
    He, Zhiyi
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [6] MicroRNA-181c functions as a protective factor in a 1-methyl-4-phenylpyridinium iodide-induced cellular Parkinson's disease model via BCL2L11
    Wei, M.
    Cao, L. -J.
    Zheng, J. -L.
    Xue, L. -J.
    Chen, B.
    Xiao, F.
    Xu, C. -S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (14) : 3296 - 3304
  • [7] MicroRNA-181a-5p Down-Regulation Presents Neuroprotective Effect in 1-Methyl-4-Phenylpyridinium-Induced Parkinson's Disease: An In Vitro Study
    Guo, YanLi
    Hua, Xu
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2020, 10 (01) : 63 - 70
  • [8] Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson's disease through regulating microRNA-221-3p/transforming growth factor/nuclear factor E2-related factor 2 axis
    Lang, Yue
    Zhang, Hui
    Yu, Haojia
    Li, Yu
    Liu, Xiao
    Li, Minjie
    BIOENGINEERED, 2022, 13 (01) : 930 - 940
  • [9] Immunomodulatory and neuroprotective effects of ginsenoside Rg1 in the MPTP(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) -induced mouse model of Parkinson's disease
    Zhou, Ting-ting
    Zu, Guo
    Wang, Xi
    Zhang, Xiao-gang
    Li, Shao
    Liang, Zhan-hua
    Zhao, Jie
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 29 (02) : 334 - 343
  • [10] Cannabidiol Alleviates the Damage to Dopaminergic Neurons in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson?s Disease Mice Via Regulating Neuronal Apoptosis and Neuroinflammation
    Wang, Lei
    Wu, Xinghong
    Yang, Ge
    Hu, Nan
    Zhao, Zijian
    Zhao, Lei
    Li, Shengyu
    NEUROSCIENCE, 2022, 498 : 64 - 72